2,2'-(Propane-2,2-diyl)bis(4-phenyl-4,5-dihydrooxazole)
CAS : 276254-59-2
Ref. 3D-BLA25459
1g | Arrêté | ||
50mg | Arrêté | ||
100mg | Arrêté | ||
250mg | Arrêté | ||
500mg | Arrêté |
Informations sur le produit
2,2'-(Propane-2,2-diyl)bis(4-phenyl-4,5-dihydrooxazole) (SSR591813) is a serotonin reuptake inhibitor that has been shown to have therapeutic potential for the treatment of depression. SSR591813 acts as a serotonin reuptake inhibitor by binding to the serotonin transporter and inhibiting its function. SSR591813 also has anti-alkylating properties and may be useful in the treatment of cancer.